Overexpression of CRM1: A characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy

Weimin Gao; Chuanwen Lu; Lixia Chen; Phouthone Keohavong

doi:10.1097/JTO.0000000000000485

Overexpression of CRM1: A characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy

Weimin Gao
, Chuanwen Lu
, Lixia Chen
, Phouthone Keohavong

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	815-825
Number of pages	11
Journal	Journal of Thoracic Oncology
Volume	10
Issue number	5
DOIs	https://doi.org/10.1097/JTO.0000000000000485
State	Published - May 30 2015
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

Oncology
Pulmonary and Respiratory Medicine

Keywords

CRM1
Combination therapy
Leptomycin B
Lung cancer
p53

Access to Document

10.1097/JTO.0000000000000485

Cite this

@article{9c711e46f15b4859bf343f5aa7045281,

title = "Overexpression of CRM1: A characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy",

keywords = "CRM1, Combination therapy, Leptomycin B, Lung cancer, p53",

author = "Weimin Gao and Chuanwen Lu and Lixia Chen and Phouthone Keohavong",

note = "Publisher Copyright: {\textcopyright} 2015 by the International Association for the Study of Lung Cancer.",

year = "2015",

month = may,

day = "30",

doi = "10.1097/JTO.0000000000000485",

language = "English",

volume = "10",

pages = "815--825",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Overexpression of CRM1

T2 - A characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy

AU - Gao, Weimin

AU - Lu, Chuanwen

AU - Chen, Lixia

AU - Keohavong, Phouthone

PY - 2015/5/30

Y1 - 2015/5/30

KW - CRM1

KW - Combination therapy

KW - Leptomycin B

KW - Lung cancer

KW - p53

UR - https://www.scopus.com/pages/publications/84938286562

UR - https://www.scopus.com/pages/publications/84938286562#tab=citedBy

U2 - 10.1097/JTO.0000000000000485

DO - 10.1097/JTO.0000000000000485

M3 - Article

C2 - 25629636

AN - SCOPUS:84938286562

SN - 1556-0864

VL - 10

SP - 815

EP - 825

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 5

ER -

Overexpression of CRM1: A characteristic feature in a transformed phenotype of lung carcinogenesis and a molecular target for lung cancer adjuvant therapy

UN SDGs

ASJC Scopus Subject Areas

Keywords

Access to Document

Other files and links

Fingerprint

Cite this